Additionally, transcriptomic data demonstrated a significant increase in the PRMT5 expression level of HCC compared to dysplastic nodules with p < 0.01 (Figure 1d), indicating a progressive activation of PRMT5 during liver cancer development and progression. This evidence concerns the gene PRMT5 and hepatocellular carcinoma.